MEaDvise
MEaDvise improves pre-diabetic and diabetic patients’ outcomes and reduces the cost for insurers and individuals through personalized risk identification, care coordination, and digital health intervention. MEaDvise Team: Abbas Shojaee
Read MoreKrouzon Pharmaceuticals, Inc.
Krouzon Pharmaceuticals, Inc. is developing a first-in-class treatment for ultra-rare orphan pediatric skeletal disorders. Krouzon Pharmaceuticals, Inc. Team: Jacob V. P. Eswarakumar
Read MoreELIV5
ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence. ELIV5 Team: Choukri Ben…
Read MoreYiviva
Yiviva is a biotechnology company developing high-quality, evidence-based, botanical products to address aging-associated diseases. Yiviva Team: Peikwen Cheng Shwu-Huey Liu
Read MoreCytosolix
Cytosolix is developing a small-molecule tumor targeted chemotherapy platform. Cytosolix Team: John C. Deacon, Ph.D., Founder and President
Read More